Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 46–60 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5272 ACTA1 Gene Myopathy (Scapulohumeroperoneal) Genetic Test This genetic test identifies mutations in the ACTA1 gene associated with autosomal dominant scapulohumeroperoneal myopathy.	Peripheral whole blood (EDTA tube, 4 ml)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACTA1 gene mutations", "Point mutations", "Small insertions/deletions", "Splice-site variants"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication"] Indications ["Suspected scapulohumeroperoneal myopathy", "Family history of myopathy", "Congenital neuromuscular disorder"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.2 Clinical summary This genetic test identifies mutations in the ACTA1 gene associated with autosomal dominant scapulohumeroperoneal myopathy.
TEST-5238 ACTA1 Gene Myopathy with Fiber‑Type Disproportion Genetic Test This genetic test analyzes the ACTA1 gene for mutations associated with congenital myopathy with fibre-type disproportion.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACTA1 gene sequence", "Copy Number Variants in ACTA1"] Parameters [] Preparation ["Genetic counselling session required", "No fasting required"] Indications ["Infants and children with hypotonia, motor delay, or muscle weakness", "Adults with undiagnosed myopathy", "Individuals with a family history of neuromuscular disease"] Measurement technique Confirm with laboratory Codes LOINC: 78603-1 ICD-10: G71.2, Z15.89, Z13.89 Clinical summary This genetic test analyzes the ACTA1 gene for mutations associated with congenital myopathy with fibre-type disproportion.
TEST-4096 ACTA2 Gene (Familial Thoracic Aortic Aneurysm Type 6) Genetic Test This test analyzes the entire coding region of the ACTA2 gene using Next-Generation Sequencing (NGS) to detect pathogenic variants associated with Familial Thoracic Aortic Aneurysm...	Peripheral Whole Blood	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACTA2 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No fasting required", "May eat and drink normally before sample collection"] Indications ["Personal or family history of unexplained aortic dilation", "Personal or family history of aortic dissection", "Personal or family history of sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 55247-0 ICD-10: I71.2 Clinical summary This test analyzes the entire coding region of the ACTA2 gene using Next-Generation Sequencing (NGS) to detect pathogenic variants associated with Familial Thoracic Aortic Aneurysm Type 6.
TEST-4166 ACTA2 Gene Multisystemic Smooth Muscle Dysfunction Syndrome Genetic Test This genetic test analyzes the ACTA2 gene for mutations associated with Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS). It identifies pathogenic variants linked to condit...	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTA2 gene", "Missense, nonsense, splice-site, and small insertion/deletion mutations"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Clinical features suggestive of MSMDS", "Family history of ACTA2-related disease", "Unexplained thoracic aortic aneurysm/stroke in young adults"] Measurement technique Confirm with laboratory Codes LOINC: 21678-0 ICD-10: Q87.89 Clinical summary This genetic test analyzes the ACTA2 gene for mutations associated with Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS). It identifies pathogenic variants linked to conditions like thoracic aortic aneurysm, moyamoya disease, and congenital mydriasis.
TEST-4180 ACTB Gene Dystonia (Juvenile-Onset) Genetic Test This genetic test detects pathogenic variants in the ACTB gene associated with juvenile-onset dystonia.	EDTA whole blood	2–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTB gene", "Copy Number Variations (CNV) in the ACTB gene"] Parameters [] Preparation [] Indications ["Suspected ACTB-related dystonia", "Genetic counselling for families with dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 94872-2 ICD-10: G24.9 Clinical summary This genetic test detects pathogenic variants in the ACTB gene associated with juvenile-onset dystonia.
TEST-4430 ACTC1 Gene Atrial Septal Defect Type 5 Genetic Test This test identifies mutations in the ACTC1 gene associated with Atrial Septal Defect Type 5.	Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the ACTC1 gene", "Cardiac actin gene variants"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue cardiac medication"] Indications ["Diagnosis of Atrial Septal Defect Type 5", "Family cascade screening", "Personalized cardiac management", "Pre-implantation genetic diagnosis (PGD) counseling"] Measurement technique Confirm with laboratory Codes LOINC: 91847-1 ICD-10: Q21.1 Clinical summary This test identifies mutations in the ACTC1 gene associated with Atrial Septal Defect Type 5.
TEST-4306 ACTC1 Gene Cardiomyopathy (Dilated Type 1R) Genetic Test This genetic test identifies pathogenic variants in the ACTC1 gene associated with dilated cardiomyopathy type 1R.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTC1 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Personal or family history of unexplained dilated cardiomyopathy", "Young-onset heart failure", "Sudden cardiac death", "Risk stratification for athletes"] Measurement technique Confirm with laboratory Codes LOINC: 85145-6 ICD-10: I42.0 Clinical summary This genetic test identifies pathogenic variants in the ACTC1 gene associated with dilated cardiomyopathy type 1R.
TEST-5769 ACTG1 Gene Autosomal Dominant Deafness Type 20 (DFNA20) Genetic Test This test identifies pathogenic variants in the ACTG1 gene associated with autosomal dominant nonsyndromic sensorineural hearing loss (DFNA20/26).	Peripheral whole blood	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACTG1 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number alterations"] Parameters [] Preparation ["No fasting required", "Stay well hydrated", "Avoid dietary supplements 24 hours before collection", "Inform phlebotomist of all medications", "Mandatory pre-test genetic counselling session"] Indications ["Diagnosis of autosomal dominant nonsyndromic sensorineural hearing loss", "Genetic counselling for families with hearing loss", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H90.3 Clinical summary This test identifies pathogenic variants in the ACTG1 gene associated with autosomal dominant nonsyndromic sensorineural hearing loss (DFNA20/26).
TEST-2205 ACTG2 Gene Visceral Myopathy Genetic Test This test identifies genetic mutations in the ACTG2 gene associated with visceral myopathy.	Peripheral Whole Blood or Buccal Swab (DNA FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACTG2 gene sequence", "Pathogenic variants in ACTG2"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed before sample collection"] Indications ["Suspected genetic visceral myopathy", "Family history of visceral myopathy", "Need for genetic confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 54350-0 ICD-10: K59.8 Clinical summary This test identifies genetic mutations in the ACTG2 gene associated with visceral myopathy.
TEST-1872 Acute Leukemia Mini Panel (AML/ETO, INV[16], PML/RARA, BCR/ABL, TEL/AML1, MLL, E2A) Test This test identifies seven specific gene fusions commonly found in acute myeloid and lymphoblastic leukemias.	Bone Marrow Aspirate / Peripheral Blood	5–6 Working Days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["AML/ETO fusion gene", "INV[16] fusion gene", "PML/RARA fusion gene", "BCR/ABL fusion gene", "TEL/AML1 fusion gene", "MLL fusion gene", "E2A fusion gene"] Parameters [] Preparation ["Fasting is not required.", "Bring a valid Emirates ID and a doctor’s prescription.", "Sample collection is performed via hospital extraction only."] Indications ["Diagnosis and classification of acute leukemia", "Prognosis assessment", "Guidance for targeted therapy selection", "Monitoring minimal residual disease (in specific contexts)"] Measurement technique Confirm with laboratory Codes LOINC: 95727-6 ICD-10: C92.00, C91.00 Clinical summary This test identifies seven specific gene fusions commonly found in acute myeloid and lymphoblastic leukemias.
TEST-115 Acute Lymphoblastic Leukemia (ALL) Cytogenetics Panel Test This diagnostic test evaluates chromosomal abnormalities in leukemia cells using karyotyping and FISH.	Bone marrow aspirate and peripheral blood	4 working days	2,700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal abnormalities (e.g., translocations, aneuploidy)", "Specific genetic markers (e.g., t(9;22), t(12;21))"] Parameters [] Preparation [] Indications ["Diagnosis of ALL", "Risk stratification in ALL", "Guiding therapeutic decisions (e.g., TKI eligibility, HSCT)", "Monitoring response to therapy"] Measurement technique Confirm with laboratory Codes LOINC: 48801-6 ICD-10: C91.00 Clinical summary This diagnostic test evaluates chromosomal abnormalities in leukemia cells using karyotyping and FISH.
TEST-109 Acute Myeloid Leukemia (AML) Cytogenetics Panel Test This test evaluates chromosomal abnormalities in blood and bone marrow cells to diagnose, classify, and determine the prognosis of Acute Myeloid Leukemia (AML).	Peripheral Whole Blood & Bone Marrow	4 working days	3,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Chromosomal aberrations (translocations, inversions, deletions, additions)", "Karyotype complexity", "Specific AML-defining genetic markers"] Parameters [] Preparation ["No fasting required.", "Inform physician about all anticoagulants.", "Complete Chromosome and FISH Analysis Requisition Form (Form 17)."] Indications ["Diagnosis of suspected Acute Myeloid Leukemia (AML)", "Risk stratification and prognostication in confirmed AML", "Guiding therapeutic decisions in AML", "Monitoring for minimal residual disease (in specific contexts)"] Measurement technique Confirm with laboratory Codes LOINC: 91836-7 ICD-10: C92.0 Clinical summary This test evaluates chromosomal abnormalities in blood and bone marrow cells to diagnose, classify, and determine the prognosis of Acute Myeloid Leukemia (AML).
TEST-5072 ACVR1 Gene Sequencing for Fibrodysplasia Ossificans Progressiva (FOP) Test This test identifies mutations within the ACVR1 gene associated with Fibrodysplasia Ossificans Progressiva (FOP).	Peripheral Blood (EDTA Whole Blood)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACVR1 gene mutations", "Coding regions and splice sites"] Parameters [] Preparation [] Indications ["Suspected Fibrodysplasia Ossificans Progressiva (FOP)", "Family history of FOP", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 92889-1 ICD-10: M61.1 Clinical summary This test identifies mutations within the ACVR1 gene associated with Fibrodysplasia Ossificans Progressiva (FOP).
TEST-2789 ACVR2B Gene Heterotaxy, Visceral Type 4 Genetic Test This test evaluates the ACVR2B gene for pathogenic variants associated with heterotaxy syndrome, visceral type 4.	Peripheral blood or saliva	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ACVR2B gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["No special preparation required", "Provide detailed clinical history", "Provide prior genetic counselling session report with pedigree chart"] Indications ["Suspected heterotaxy syndrome, visceral type 4", "Congenital heart disease with laterality defects", "Family history of heterotaxy"] Measurement technique Confirm with laboratory Codes LOINC: 21652-6 ICD-10: Q89.3 Clinical summary This test evaluates the ACVR2B gene for pathogenic variants associated with heterotaxy syndrome, visceral type 4.
TEST-4536 ACVRL1 Gene (Hereditary Hemorrhagic Telangiectasia Type 2) Genetic Test This genetic test evaluates the ACVRL1 gene for pathogenic variants associated with Hereditary Hemorrhagic Telangiectasia Type 2 (HHT2).	Peripheral Whole Blood (EDTA)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ACVRL1 gene sequence", "Single Nucleotide Variants (SNVs)", "Small Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist about anticoagulant/antiplatelet therapy", "Pre-test genetic counselling is mandatory"] Indications ["Diagnosis of HHT2 in symptomatic individuals", "Carrier screening in families with known ACVRL1 mutations", "Prenatal diagnosis", "Preimplantation genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 82588-6 ICD-10: I78.0 Clinical summary This genetic test evaluates the ACVRL1 gene for pathogenic variants associated with Hereditary Hemorrhagic Telangiectasia Type 2 (HHT2).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories